Brachytherapy utilization rate and effect on survival in cervical cancer patients in Korea

Objective: External beam radiation therapy (EBRT) with concurrent chemotherapy followed by intracavitary brachytherapy is the standard treatment in locally advanced cervical cancer. This study examined the brachytherapy utilization rate and evaluated the effect of brachytherapy on survival in cervic...

Full description

Saved in:
Bibliographic Details
Published in:Journal of gynecologic oncology 2021-11, Vol.32 (6), p.1
Main Authors: Young Ae Kim, Min Soo Yang, Minae Park, Min Gee Choi, So Young Kim, Yeon-joo Kim
Format: Article
Language:Korean
Subjects:
Brachytherapy
Korea
Radiotherapy
Survival
Uterine Cervical Neoplasms
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective: External beam radiation therapy (EBRT) with concurrent chemotherapy followed by intracavitary brachytherapy is the standard treatment in locally advanced cervical cancer. This study examined the brachytherapy utilization rate and evaluated the effect of brachytherapy on survival in cervical cancer patients in Korea. Methods: In this study, data from the Korea Central Cancer Registry and Korean National Health Insurance Service and data on mortality from Statistics Korea were linked and used. Patients with other cancers, distant metastasis at diagnosis, or unknown stage or who underwent hysterectomy were excluded. A total of 12,721 cervical cancer patients were analyzed in this study. Results: The brachytherapy utilization rate (%) was calculated as the proportion of patients who received brachytherapy among those who received curative EBRT. The brachytherapy utilization rate decreased from 84% in 2005 to 78% in 2013 (p
ISSN:2005-0380